FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

Journal: Journal of Clinical Investigation

Published: 2020-09-01

DOI: 10.1172/jci130323

Affiliations: 20

Authors: 25

Go to article
Institutions Share
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.29
UNC Department of Genetics, United States of America (USA) 0.15
UNC School of Medicine, United States of America (USA) 0.08
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.07
Hospital Clinic of Barcelona, Spain 0.07
Spanish Research Group on Breast Cancer (GEICAM), Spain 0.06
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain 0.04
UNC Division of Hematology/Oncology, United States of America (USA) 0.04
Department of Molecular and Cellular Biology, BCM, United States of America (USA) 0.04
Hospital Clínico Universitario de Valencia, Spain 0.03
UNC School of Dentistry, United States of America (USA) 0.02
Provincial Hospital of Castellón, Spain 0.01
SOLTI Breast Cancer Research Group, Spain 0.01
UNC Department of Pathology and Laboratory Medicine, United States of America (USA) 0.01
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain 0.01
Biomedical Research Institute (INCLIVA), Spain 0.01
Pompeu Fabra University (UPF), Spain 0.01
Hospital del Mar, Spain 0.01
Hospital del Mar Medical Research Institute (IMIM), Spain 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER